OTCMKTS:NBIO
Nascent Biotech, Inc. Stock Company Profile
$0.0700
+0 (+0%)
At Close: Jul 03, 2024
Information
623 17th Street, Suite 4
Vero Beach FL 32960
612 961 5656
www.nascentbiotech.com
Industry: Biotechnology
Sector: Healthcare
Description
Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. In addition, the company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. Nascent Biotech, Inc. is based in Vero Beach, Florida.
